David B. Lewis

Publication Details

  • CROSS-REACTIVE NEUTRALIZING ANTIBODY AGAINST PANDEMIC 2009 H1N1 INFLUENZA A VIRUS IN INTRAVENOUS IMMUNOGLOBULIN PREPARATIONS PEDIATRIC INFECTIOUS DISEASE JOURNAL Hong, D. K., Tremoulet, A. H., Burns, J. C., Lewis, D. B. 2011; 30 (1): 67-69

    Abstract:

    Prepandemic intravenous immunoglobulin (IVIG) and sera from Kawasaki disease patients treated with this IVIG were analyzed for 2009 H1N1-specific microneutralization and hemagglutination inhibition antibodies. All 6 different IVIG preparations tested had significant levels of cross-reactive-specific antibody at a concentration of 2.0 g/dL of immunoglobulin. Sera from 18 of 19 Kawasaki disease patients had significant increases of cross-reactive-specific antibody after 2.0 g/kg of prepandemic IVIG. These results suggest a role for adjunctive IVIG therapy for severe and/or drug-resistant 2009 H1N1 virus and other highly antigenically drifted influenza strains, particularly in the immunocompromised.

    View details for DOI 10.1097/INF.0b013e3181f127be

    View details for Web of Science ID 000285498800017

    View details for PubMedID 20724956

Stanford Medicine Resources:

Footer Links: